Drug Pricing & Affordability
Expert articles and analysis related to drug pricing & affordability.
AI Summary — Last 7 Days
No recent expert commentary on Drug Pricing & Affordability in the last 7d.
Related Articles
MFP Effectuation and the SDRA: The Possibility of ASP Spirals in Competitive Drug Classes[
Federal appeals court revives part of Teva's IRA case as Austedo price cuts loom
After a lower court rejected Teva's case last fall, a federal appeals court has revived part of the drugmaker’s lawsuit against Medicare negotiations. The DC Circuit Court ruled on Tuesday that Teva...
Response to Senate Finance Committee request for information on policies for lowering drug prices
Response to Senate Finance Committee request for information on policies for lowering drug prices Brookings
Comments on the Medicare Drug Price Negotiation Program proposed rule for IPAY 2029
Comments on the Medicare Drug Price Negotiation Program proposed rule for IPAY 2029 Brookings
Legislative Proposals Aim to Modify the 340B Program
STAT+: The White House declares ‘promises made, promises kept’ on lowering drug prices. Nice try
In its effort to lower drug prices, the White House has declared "promises made, promises kept." That's a narrative that doesn't reflect the full story.
Trump is taking credit for lower list prices. But a Biden-era law did a lot of the heavy lifting
List prices for brand-name drugs have declined significantly in 2026. But the reasons behind it may have more to do with a Biden-era law than any of the Trump administration's recent initiatives, expe...
Businesses increase support for hospital price caps
Business groups increasingly support various approaches to cap hospital prices. Although many business groups continue their traditional opposition to any government price controls, an increasing numb...
AHA comments on CMS proposal to codify Medicare Drug Price Negotiation Program regulations
AHA comments on CMS proposal to codify Medicare Drug Price Negotiation Program regulations American Hospital Association
A recent historic drop in drug prices is largely driven by market forces, Joyce explains
The post A recent historic drop in drug prices is largely driven by market forces, Joyce explains appeared first on USC Schaeffer.